Crowdonomics
All companies
Hale Therapeutics logo

Hale Therapeutics

Operating

Hava Health Inc

Software & AI · Founded 2018

Proprietary medical vaporizer and mobile application to help smokers quit nicotine more easily

Valuation cap ⓘ
$15.0M
As of May 2022 · from Reg CF Offering (2022) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$521,500
Crowd $27K · Private $495K · 2 rounds since 2019

Financials

FY2019–FY2020 · from SEC filings · hover any figure for its source
$0
−$430K
2019
$0
−$641K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed*
FY2020 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$430,338
-$641,293
Taxes paid
$0
$0
Balance sheet
Cash
$721,754
$757,219
Accounts receivable
$68,982
$49,551
Total assets
$796,426
$852,260
Short-term debt
$1,265,078
$1,962,128
Long-term debt
$0
$0
Total liabilities
$1,265,078
$1,962,128
Other
Headcount
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$15.0M
Valuation cap
Reg CF · Note · Mar 2022

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Raised $26.5K / $1.1MValuation cap $15M

Team

2 people
Josh Israel
CEO
Devin Serago
COO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 5 annual reports (FY2021–FY2025)

Missing: 2021, 2022, 2023, 2024, 2025

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 15, 20220001893268-22-000002
    EDGAR
  • Form CFeb 25, 20220001893268-22-000001
    EDGAR
Source: ManualCIK 0001893268

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.